The risks posed to patients with cancer by the current COVID-19 pandemic demand rapid structural changes in healthcare delivery, with many positive changes likely to continue long term. An immediate critical reassessment of trial methodology based on clinical and scientific priorities is essential to ensure the resilience of clinical cancer research and optimize patient-centered care.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7258610 | PMC |
http://dx.doi.org/10.1038/s43018-020-0083-x | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!